Terms: = Lung cancer AND ERCC5, XPGC, 2073, ENSG00000134899, RP11-484I6_5, COFS3, XPG, UVDR, ERCM2 AND Treatment
33996 results:
1. A meta-analysis of recombinant human endostatin combined with NP regimen for treating non-small cell lung cancer.
Gao C; Gao C; Yuan Q
Medicine (Baltimore); 2024 May; 103(21):e38027. PubMed ID: 38788043
[TBL] [Abstract] [Full Text] [Related]
2. Sentinel Lymph Node Mapping in lung cancer: A Pilot Study for the Detection of Micrometastases in Stage I Non-Small Cell lung cancer.
Romano G; Zirafa CC; Calabrò F; Alì G; Manca G; De Liperi A; Proietti A; Manfredini B; Di Stefano I; Marciano A; Davini F; Volterrani D; Melfi F
Tomography; 2024 May; 10(5):761-772. PubMed ID: 38787018
[TBL] [Abstract] [Full Text] [Related]
3. Effects of sEH inhibition on the eicosanoid and cytokine storms in SARS-CoV-2-infected mice.
Edin ML; Gruzdev A; Graves JP; Lih FB; Morisseau C; Ward JM; Hammock BD; Bosio CM; Zeldin DC
FASEB J; 2024 May; 38(10):e23692. PubMed ID: 38786655
[TBL] [Abstract] [Full Text] [Related]
4. Real-World Analysis of Post-Progression treatment Patterns and Outcomes for
Gibson AJW; Dean ML; Litt I; Box A; Cheung WY; Navani V
Curr Oncol; 2024 Apr; 31(5):2427-2440. PubMed ID: 38785463
[No Abstract] [Full Text] [Related]
5. Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review).
Taylor J; Dubois F; Bergot E; Levallet G
Int J Oncol; 2024 Jul; 65(1):. PubMed ID: 38785155
[TBL] [Abstract] [Full Text] [Related]
6. Diagnostic and therapeutic challenges in a recurrent endometrial carcinoma in lung, 15 years after primary treatment.
Upadhyay AK; Kumar M; Prakash A; Kumar A
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38782427
[TBL] [Abstract] [Full Text] [Related]
7. cancer treatment Before and After Physician-Pharmacy Integration.
Kanter GP; Ozluk P; Chi W; Fisch MJ; Debono D; Parikh RB; Jacobson M; Bekelman JE; DeVries A
JAMA Netw Open; 2024 May; 7(5):e2412998. PubMed ID: 38780938
[TBL] [Abstract] [Full Text] [Related]
8. The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort.
Li X; Wu D; Tang J; Wu Y
J Cancer Res Clin Oncol; 2024 May; 150(5):271. PubMed ID: 38780840
[TBL] [Abstract] [Full Text] [Related]
9. 3,3'-((3,4,5-trifluoropHenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) inhibit lung cancer cell proliferation and migration.
Luo W; Chang G; Lin D; Xie H; Sun H; Li Z; Mo S; Wang R; Wang Y; Zheng Z
PLoS One; 2024; 19(5):e0303186. PubMed ID: 38776295
[TBL] [Abstract] [Full Text] [Related]
10. Evaluation of Pm2.5 Influence on Human lung cancer Cells Using a Microfluidic Platform.
Nguyen UTN; Hsieh HY; Chin TY; Wu G; Lin YP; Lee CY; Hsu YC; Fan YJ
Int J Med Sci; 2024; 21(6):1117-1128. PubMed ID: 38774761
[TBL] [Abstract] [Full Text] [Related]
11.
McMahon NP; Solanki A; Wang LG; Montaño AR; Jones JA; Samkoe KS; Tichauer KM; Gibbs SL
Theranostics; 2024; 14(7):2816-2834. PubMed ID: 38773974
[No Abstract] [Full Text] [Related]
12. Integrated analysis of single-cell and bulk RNA sequencing data reveals a myeloid cell-related regulon predicting neoadjuvant immunotherapy response across cancers.
Liu H; Sima X; Xiao B; Gulizeba H; Zhao S; Zhou T; Huang Y
J Transl Med; 2024 May; 22(1):486. PubMed ID: 38773508
[TBL] [Abstract] [Full Text] [Related]
13. The role of seven tumor-associated autoantibodies in the diagnosis, staging and treatment guidance of lung cancer.
Ma H; Wu T; Zhang Q; Ding Q
BMC Pulm Med; 2024 May; 24(1):250. PubMed ID: 38773432
[TBL] [Abstract] [Full Text] [Related]
14. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
[TBL] [Abstract] [Full Text] [Related]
15. Longitudinal changes in serum immunoglobulin G testing in patients with fibrotic avian hypersensitivity pneumonitis.
Okuda R; Takemura T; Misumi T; Sekine A; Hagiwara E; Ogura T
BMC Pulm Med; 2024 May; 24(1):245. PubMed ID: 38762468
[TBL] [Abstract] [Full Text] [Related]
16. The later-line efficacy and safety of immune checkpoint inhibitors plus anlotinib in EGFR-mutant patients with EGFR-TKI-resistant NSCLC: a single-center retrospective study.
Yin X; Liu X; Ren F; Meng X
Cancer Immunol Immunother; 2024 May; 73(7):134. PubMed ID: 38758372
[TBL] [Abstract] [Full Text] [Related]
17. Identification and analysis of prognostic immune cell homeostasis characteristics in lung adenocarcinoma.
Sun Y; Ma Q; Chen Y; Liao D; Kong F
Clin Respir J; 2024 May; 18(5):e13755. PubMed ID: 38757752
[TBL] [Abstract] [Full Text] [Related]
18. Case report: Sintilimab combined with anlotinib as neoadjuvant chemotherapy for metastatic bone tumor resection in patients with PSC.
Bao Z; Yu X; Zheng K; Zhai K; Cui H; Xu M
Front Immunol; 2024; 15():1372279. PubMed ID: 38756778
[TBL] [Abstract] [Full Text] [Related]
19. Clinic information, pathological, and imaging characteristics in 2 058 surgical patients with lung cancer from a single center.
Long B; Xiong Z; Liu S; Cheng Y; Li M; Liao W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):247-255. PubMed ID: 38755720
[TBL] [Abstract] [Full Text] [Related]
20. Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non-Small Cell lung cancer.
Wallenta Law J; Bapat B; Sweetnam C; Mohammed H; McBratney A; Izano MA; Scannell Bryan M; Spencer S; Schroeder B; Hostin D; Simon GR; Berry AB
JCO Precis Oncol; 2024 May; 8():e2400075. PubMed ID: 38754057
[TBL] [Abstract] [Full Text] [Related]
[Next]
